Quantum Biopharma Ltd (QNTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,579 | -15,448 | -9,958 | -26,704 | -20,555 |
| Depreciation Amortization | 2,384 | 2,237 | 1,130 | 4,535 | 3,380 |
| Accounts receivable | 1,475 | 5 | -51 | 215 | 265 |
| Other Working Capital | 920 | -226 | 0 | -7,120 | -5,548 |
| Other Operating Activity | 1,825 | 5,168 | 4,124 | 741 | 450 |
| Operating Cash Flow | $-9,976 | $-8,263 | $-4,754 | $-28,333 | $-22,007 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 443 | N/A | N/A | N/A | N/A |
| PPE Investments | N/A | N/A | N/A | -114 | -117 |
| Net Acquisitions | 32 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -745 | N/A | N/A | -402 | -6 |
| Sale Of Investment | N/A | N/A | N/A | 158 | 158 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -250 | -250 |
| Other Investing Activity | 0 | 0 | 0 | 12,481 | 12,481 |
| Investing Cash Flow | $-270 | $N/A | $N/A | $12,123 | $12,516 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 20 | 20 | 9 | N/A | N/A |
| Common Stock Repurchased | -2,958 | -2,958 | -2,958 | -1,926 | -1,926 |
| Other Financing Activity | -164 | -109 | -54 | -143 | -94 |
| Financing Cash Flow | $-3,101 | $-3,047 | $-3,004 | $-2,069 | $-2,020 |
| Beginning Cash Position | 16,981 | 16,981 | 16,981 | 35,260 | 35,260 |
| End Cash Position | 3,634 | 5,671 | 9,223 | 16,981 | 23,748 |
| Net Cash Flow | $-13,347 | $-11,310 | $-7,758 | $-18,279 | $-11,511 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,976 | -8,263 | -4,754 | -28,333 | -22,007 |
| Capital Expenditure | N/A | N/A | N/A | -114 | -117 |
| Free Cash Flow | -9,976 | -8,263 | -4,754 | -28,447 | -22,124 |